BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Andrea Apolo
small cell cancer with that kind of paradigm in terms of the systemic therapies that I use. But in general, patients with variant histologies, I treat them as urothelial carcinoma until we have prospective data showing that another regimen or something different would be better for these patients.
0
💬
0
Comments
Log in to comment.
There are no comments yet.